Heuking Kühn Lüer Wojtek advised WuXi Biologics on this transaction.Globally operating Chinese group WuXi Biologics completed the acquisition of a drug substance facility from Bayer AG…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Federica Tiefenthaler
…
This content is for Standard 1 Year members only. LoginJoin Now